A multicenter randomized placebo-control
โ
Roger Kurlan; Giovanna Crespi; Barbara Coffey; Kirsten Mueller-Vahl; Stephen Kov
๐
Article
๐
2012
๐
John Wiley and Sons
๐
English
โ 730 KB
Background: Dopamine agonists could theoretically normalize the suspected central dopamine hypersensitivity in Tourette's syndrome. Methods: There was a multicenter randomized, placebo-controlled, double-blind clinical trial of pramipexole given for 6 weeks in 63 children and adolescents with Touret